Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotex has developed multiple novel medical technologies, with at least two successfully commercialized via spin-offs (Visualase—acquired by Medtronic—and Base Pair BioTechnologies). The company maintains a pipeline of early-stage diagnostic and therapeutic devices. It partners with startups to accelerate product development, regulatory strategy, and manufacturing. Recent clinical activities include supporting Ictero Medical’s cryoablation technology for gallbladder disease toward regulatory clearance
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotex.